Cite
Safety of Antiplatelet Therapy in Noncardioembolic Ischemic Stroke With Thrombocytopenia: The CASE II Study
MLA
Dongjuan Xu, et al. “Safety of Antiplatelet Therapy in Noncardioembolic Ischemic Stroke With Thrombocytopenia: The CASE II Study.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, vol. 13, no. 16, Aug. 2024. EBSCOhost, https://doi.org/10.1161/JAHA.123.032327.
APA
Dongjuan Xu, Huan Zhou, Tingxia Zhang, Weiwei Gong, Jieming Zhong, Han Yu, Fujian Chen, Wansi Zhong, Shenqiang Yan, & Min Lou. (2024). Safety of Antiplatelet Therapy in Noncardioembolic Ischemic Stroke With Thrombocytopenia: The CASE II Study. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 13(16). https://doi.org/10.1161/JAHA.123.032327
Chicago
Dongjuan Xu, Huan Zhou, Tingxia Zhang, Weiwei Gong, Jieming Zhong, Han Yu, Fujian Chen, Wansi Zhong, Shenqiang Yan, and Min Lou. 2024. “Safety of Antiplatelet Therapy in Noncardioembolic Ischemic Stroke With Thrombocytopenia: The CASE II Study.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 13 (16). doi:10.1161/JAHA.123.032327.